Ads
    Related paper
  1. FORMULATION AND DEVELOPMENT OF TELMISARTAN TABLETS EMPLOYING FACTORIAL DESIGNS AND STABILITY
  2. FORMULATION DEVELOPMENT AND OPTIMIZATION OF TELMISARTAN TABLETS EMPLOYING βCD STARCH 1500 AND SOLUPLUS
  3. FORMULATION DEVELOPMENT OF VALSARTAN FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH – OPTIMIZATION BY 23 FACTORIAL DESIGN
  4. DESIGN, DEVELOPMENT AND FORMULATION OF DISPERSIBLE TABLETS CONTAINING ANTIRETROVIRAL AS A DARUNAVIR BY DIRECT COMPRESSION USING 23 FULL FACTORIAL DESIGNS
  5. OPTIMIZATION OF TELMISARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN EMPLOYING HPβCD, PRIMOJEL AND TWEEN 80
  6. FORMULATION AND EVALUATION OF LOSARTAN FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH ? OPTIMIZATION BY 23 FACTORIAL DESIGN
  7. ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF TELMISARTAN EMPLOYING β-CYCLODEXTRIN AND SOLUPLUS – A FACTORIAL STUDY
  8. FACTORIAL STUDIES ON ENHANCEMENT OF DISSOLUTION RATE OF TELMISARTAN TABLETS BY CD COMPLEXATION AND SOLID DISPERSION TECHNIQUES
  9. FORMULATION AND OPTIMIZATION OF TELMISARTAN MULTIPARTICULATE SYSTEM USING A 22 FACTORIAL DESIGN
  10. FORMULATION AND IN VIRTO EVALUATION OF TELMISARTAN TABLETS: INFLUENCE OF SYNTHETIC AND NATURAL BINDERS